Remimazolam versus etomidate for anesthesia induction in shock patients undergoing emergency surgery

Phase 4, randomised trial of remimazolam, etomidate and esketamine in Shock (2 arms), sponsored by Putian First Hospital. Primary endpoints: Area under the baseline mean arterial pressure curve over the first 15 minutes after induction, Change in cardiac index from baseline over the first 15 minutes after induction and 1 more. Planned start Dec 2022; status: not yet recruiting.